Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histone-Lysine N-Methyltransferase | 2 | 2024 | 134 | 1.530 |
Why?
|
| Ovarian Neoplasms | 5 | 2024 | 573 | 1.440 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 3 | 2024 | 116 | 1.010 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2024 | 801 | 0.790 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 910 | 0.570 |
Why?
|
| Cell Line, Tumor | 5 | 2024 | 3397 | 0.340 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2024 | 1395 | 0.320 |
Why?
|
| Surgeons | 2 | 2020 | 327 | 0.230 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 6 | 1 | 2024 | 2 | 0.230 |
Why?
|
| Electroretinography | 1 | 2024 | 50 | 0.220 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2024 | 21 | 0.220 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2024 | 35 | 0.220 |
Why?
|
| Histocompatibility Antigens | 1 | 2024 | 106 | 0.210 |
Why?
|
| Macaca mulatta | 1 | 2024 | 186 | 0.210 |
Why?
|
| DNA Transposable Elements | 1 | 2024 | 118 | 0.210 |
Why?
|
| Endogenous Retroviruses | 1 | 2024 | 38 | 0.210 |
Why?
|
| Exons | 1 | 2024 | 352 | 0.200 |
Why?
|
| Tumor Microenvironment | 2 | 2024 | 668 | 0.200 |
Why?
|
| Tomography, Optical Coherence | 1 | 2024 | 234 | 0.200 |
Why?
|
| Alternative Splicing | 1 | 2024 | 227 | 0.190 |
Why?
|
| Clinical Competence | 2 | 2020 | 1149 | 0.190 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2024 | 870 | 0.170 |
Why?
|
| Signal Transduction | 2 | 2024 | 5092 | 0.170 |
Why?
|
| Tonsillitis | 1 | 2020 | 8 | 0.170 |
Why?
|
| Consensus | 2 | 2020 | 683 | 0.160 |
Why?
|
| Tracheotomy | 1 | 2019 | 25 | 0.160 |
Why?
|
| Genomics | 1 | 2024 | 797 | 0.150 |
Why?
|
| Metabolomics | 1 | 2024 | 689 | 0.150 |
Why?
|
| Esophagoscopy | 1 | 2020 | 210 | 0.150 |
Why?
|
| Mice | 3 | 2024 | 17828 | 0.150 |
Why?
|
| Animals | 6 | 2024 | 37243 | 0.140 |
Why?
|
| Quality Indicators, Health Care | 1 | 2020 | 308 | 0.140 |
Why?
|
| Proteomics | 1 | 2024 | 1112 | 0.140 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 4316 | 0.130 |
Why?
|
| Disease Progression | 1 | 2024 | 2752 | 0.130 |
Why?
|
| Colorectal Neoplasms | 1 | 2024 | 792 | 0.130 |
Why?
|
| Cell Proliferation | 1 | 2024 | 2480 | 0.130 |
Why?
|
| Female | 6 | 2024 | 74016 | 0.090 |
Why?
|
| Pediatrics | 1 | 2019 | 1079 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 2152 | 0.090 |
Why?
|
| Humans | 10 | 2024 | 138972 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2020 | 1183 | 0.080 |
Why?
|
| Delphi Technique | 2 | 2020 | 290 | 0.070 |
Why?
|
| Color Vision Defects | 1 | 2024 | 9 | 0.060 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2024 | 18 | 0.060 |
Why?
|
| Homozygote | 1 | 2024 | 202 | 0.050 |
Why?
|
| BRCA2 Protein | 1 | 2024 | 62 | 0.050 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2024 | 50 | 0.050 |
Why?
|
| Fluorescein Angiography | 1 | 2024 | 167 | 0.050 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2024 | 78 | 0.050 |
Why?
|
| Interferons | 1 | 2024 | 195 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2024 | 397 | 0.050 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2023 | 20 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2024 | 190 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2024 | 335 | 0.050 |
Why?
|
| Carcinogenesis | 1 | 2024 | 215 | 0.050 |
Why?
|
| Transcription Factor AP-1 | 1 | 2023 | 88 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2024 | 731 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2024 | 310 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 322 | 0.040 |
Why?
|
| Esophagoscopes | 1 | 2020 | 5 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2024 | 527 | 0.040 |
Why?
|
| Computational Biology | 1 | 2024 | 650 | 0.040 |
Why?
|
| Foreign Bodies | 1 | 2020 | 106 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2019 | 286 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2024 | 825 | 0.040 |
Why?
|
| Transcriptome | 1 | 2024 | 966 | 0.040 |
Why?
|
| Esophagus | 1 | 2020 | 257 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2024 | 1229 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2024 | 1471 | 0.030 |
Why?
|
| Macrophages | 1 | 2024 | 1543 | 0.030 |
Why?
|
| Phenotype | 1 | 2024 | 3143 | 0.030 |
Why?
|
| Child | 3 | 2020 | 21936 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2020 | 1215 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 5884 | 0.020 |
Why?
|
| Male | 1 | 2024 | 68250 | 0.010 |
Why?
|